{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:41:44Z","timestamp":1789904504029,"version":"4.0.1"},"reference-count":185,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,31]],"date-time":"2015-07-31T00:00:00Z","timestamp":1438300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","bloodreviews.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.blre.2015.07.004","type":"journal-article","created":{"date-parts":[[2015,7,20]],"date-time":"2015-07-20T13:21:18Z","timestamp":1437398478000},"page":"35-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Current concepts in the prevention of pathogen transmission via blood\/plasma-derived products for bleeding disorders"],"prefix":"10.1016","volume":"30","author":[{"given":"Giovanni","family":"Di Minno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo Federico","family":"Perno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Tiede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Canaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz","family":"G\u00fcertler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Ironside","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2015.07.004_bb0005","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev-pathol-020712-164041","article-title":"Pathogenesis of the viral hemorrhagic fevers","volume":"8","author":"Paessler","year":"2013","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.blre.2015.07.004_bb0010","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1365-2516.2012.02909.x","article-title":"Guidelines for the management of hemophilia","volume":"19","author":"Srivastava","year":"2013","journal-title":"Haemophilia"},{"issue":"Suppl. 1","key":"10.1016\/j.blre.2015.07.004_bb0015","doi-asserted-by":"crossref","first-page":"9S","DOI":"10.1111\/j.1537-2995.2012.03622.x","article-title":"Plasma components: properties, differences, and uses","volume":"52","author":"Benjamin","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2015.07.004_bb0020","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2516.2009.02131.x","article-title":"A study of reported factor VIII use around the world","volume":"16","author":"Stonebraker","year":"2010","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2015.07.004_bb0025","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1538-7836.2006.01808.x","article-title":"Mortality and causes of death in patients with hemophilia, 1992-2001: a prospective cohort study","volume":"4","author":"Plug","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2015.07.004_bb0030","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1750-1172-7-24","article-title":"Past, present and future of hemophilia: a narrative review","volume":"7","author":"Franchini","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.blre.2015.07.004_bb0035","first-page":"361","article-title":"The management of hemophilia in elderly patients","volume":"2","author":"Franchini","year":"2007","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.blre.2015.07.004_bb0040","doi-asserted-by":"crossref","first-page":"S468","DOI":"10.1016\/j.amepre.2009.12.019","article-title":"Assessing emerging infectious threats to blood safety for the blood disorders community","volume":"38","author":"Trimble","year":"2010","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.blre.2015.07.004_bb0045","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1751-2824.2008.00195.x","article-title":"Blood processing","volume":"3","author":"Hardwick","year":"2008","journal-title":"ISBT Sci Ser"},{"key":"10.1016\/j.blre.2015.07.004_bb0050","author":"World Health Organisation (WHO)"},{"key":"10.1016\/j.blre.2015.07.004_bb0055","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.3324\/haematol.2013.084145","article-title":"Pathogen safety of long-term treatments for bleeding disorders: still relevant to current practice","volume":"98","author":"Di Minno","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2015.07.004_bb0060","first-page":"366","article-title":"Factor VIII safety: plasma-derived versus recombinant products","volume":"9","author":"Gringeri","year":"2011","journal-title":"Blood Transfus"},{"key":"10.1016\/j.blre.2015.07.004_bb0065","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1055\/s-0033-1358798","article-title":"Pathogen safety of long-term treatments for bleeding disorders: (un)predictable risks and evolving threats","volume":"39","author":"Di Minno","year":"2013","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.blre.2015.07.004_bb0070","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1111\/trf.12371","article-title":"Transfusion-transmitted emerging infectious diseases: 30years of challenges and progress","volume":"53","author":"Stramer","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2015.07.004_bb0075","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/j.1537-2995.2008.01718.x","article-title":"Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus","volume":"48","author":"Hourfar","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2015.07.004_bb0080","author":"World Health Organisation (WHO)"},{"key":"10.1016\/j.blre.2015.07.004_bb0085","author":"World Federation of Hemophilia (WFH)"},{"key":"10.1016\/j.blre.2015.07.004_bb0090","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/1743-422X-10-239","article-title":"Medical virology of hepatitis B: how it began and where we are now","volume":"10","author":"Gerlich","year":"2013","journal-title":"Virol J"},{"key":"10.1016\/j.blre.2015.07.004_bb0095","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1742-4690-10-56","article-title":"A novel acute HIV infection staging system based on 4th generation immunoassay","volume":"10","author":"Ananworanich","year":"2013","journal-title":"Retrovirology"},{"key":"10.1016\/j.blre.2015.07.004_bb0100","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/trf.12423","article-title":"Pathogen inactivation and removal methods for plasma-derived clotting factor concentrates","volume":"54","author":"Klamroth","year":"2014","journal-title":"Transfusion"},{"issue":"Suppl. 3","key":"10.1016\/j.blre.2015.07.004_bb0105","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1111\/trf.12298","article-title":"How safe is safe: new human immunodeficiency virus Type 1 variants missed by nucleic acid testing","volume":"53","author":"Muller","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2015.07.004_bb0110","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1111\/trf.12299","article-title":"Prevalence of human immunodeficiency virus RNA and antibody in first-time, lapsed, and repeat blood donations across five international regions and relative efficacy of alternative screening scenarios","volume":"53","author":"Bruhn","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2015.07.004_bb0115","doi-asserted-by":"crossref","first-page":"14615","DOI":"10.3748\/wjg.v20.i40.14615","article-title":"Recent advances in molecular diagnostics of hepatitis B virus","volume":"20","author":"Datta","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.blre.2015.07.004_bb0120","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10096-013-1930-9","article-title":"Surface antigen-negative hepatitis B virus infection in Dutch blood donors","volume":"33","author":"Lieshout-Krikke","year":"2014","journal-title":"Eur J Clin Microbiol"},{"key":"10.1016\/j.blre.2015.07.004_bb0125","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3851\/IMP1556","article-title":"Potential threat of drug-resistant and vaccine-escape HBV mutants to public health","volume":"15","author":"Teo","year":"2010","journal-title":"Antivir Ther"},{"key":"10.1016\/j.blre.2015.07.004_bb0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/0973-6247.126683","article-title":"Hepatitis C virus: Screening, diagnosis, and interpretation of laboratory assays","volume":"8","author":"Gupta","year":"2014","journal-title":"Asian J Transfus Sci"},{"key":"10.1016\/j.blre.2015.07.004_bb0135","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1053\/tmrv.1997.0110155","article-title":"The incidence\/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection","volume":"11","author":"Kleinman","year":"1997","journal-title":"Transfus Med Rev"},{"issue":"Suppl. 3","key":"10.1016\/j.blre.2015.07.004_bb0140","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1111\/trf.12178","article-title":"Comparative analysis of triplex nucleic acid test assays in United States blood donors","volume":"53","author":"Stramer","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2015.07.004_bb0145","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/655832","article-title":"Novel Treponema pallidum serologic tests: a paradigm shift in syphilis screening for the 21st century","volume":"51","author":"Sena","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2015.07.004_bb0150","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1056\/NEJMoa030969","article-title":"Transmission of West Nile virus through blood transfusion in the United States in 2002","volume":"349","author":"Pealer","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2015.07.004_bb0155","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1537-2995.2012.03742.x","article-title":"Emerging infectious agents and the nation's blood supply: responding to potential threats in the 21st century","volume":"53","author":"Glynn","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2015.07.004_bb0160","first-page":"563","article-title":"West Nile virus in the transfusion setting with a special focus on Italian preventive measures adopted in 2008-2012 and their impact on blood safety","volume":"11","author":"Pupella","year":"2013","journal-title":"Blood Transfus"},{"key":"10.1016\/j.blre.2015.07.004_bb0165","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.3201\/eid1210.060610","article-title":"Novel chikungunya virus variant in travelers returning from Indian Ocean islands","volume":"12","author":"Parola","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.blre.2015.07.004_bb0170","first-page":"199","article-title":"The Chikungunya epidemic in Italy and its repercussion on the blood system","volume":"6","author":"Liumbruno","year":"2008","journal-title":"Blood Transfus"},{"key":"10.1016\/j.blre.2015.07.004_bb0175","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1111\/trf.12790","article-title":"Chikungunya virus: new risk to transfusion safety in the Americas","volume":"54","author":"Petersen","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2015.07.004_bb0180","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1371\/journal.ppat.0030201","article-title":"A single mutation in chikungunya virus affects vector specificity and epidemic potential","volume":"3","author":"Tsetsarkin","year":"2007","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.blre.2015.07.004_bb0185","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/bjh.12060","article-title":"Parvovirus transmission by blood products - a cause for concern?","volume":"159","author":"Norja","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2015.07.004_bb0190","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1423-0410.2010.01445.x","article-title":"Prevalence of nucleic acid sequences specific for human parvoviruses, hepatitis A and hepatitis E viruses in coagulation factor concentrates","volume":"100","author":"Modrow","year":"2011","journal-title":"Vox Sang"},{"key":"10.1016\/j.blre.2015.07.004_bb0195","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/trf.12153","article-title":"Evidence for the continued transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates","volume":"53","author":"Soucie","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2015.07.004_bb0200","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1128\/CMR.15.3.485-505.2002","article-title":"Human parvovirus B19","volume":"15","author":"Heegaard","year":"2002","journal-title":"Clin Microbiol Rev"},{"issue":"Suppl. 5","key":"10.1016\/j.blre.2015.07.004_bb0205","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2516.2010.02292.x","article-title":"Viral pathogens","volume":"16","author":"Ragni","year":"2010","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2015.07.004_bb0210","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/S0140-6736(14)61187-9","article-title":"Hepatitis E screening for blood donations: an urgent need?","volume":"384","author":"Pawlotsky","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2015.07.004_bb0215","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-3148.2006.00652.x","article-title":"Transfusion-transmitted hepatitis E in a 'nonhyperendemic' country","volume":"16","author":"Boxall","year":"2006","journal-title":"Transfus Med"},{"key":"10.1016\/j.blre.2015.07.004_bb0220","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3201\/eid1304.061387","article-title":"Transfusion-associated hepatitis E, France","volume":"13","author":"Colson","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.blre.2015.07.004_bb0225","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2014.19.21.20812","article-title":"Transfusion-transmitted hepatitis E in Germany, 2013","volume":"19","author":"Huzly","year":"2014","journal-title":"Euro Surveill"},{"issue":"Suppl. 3","key":"10.1016\/j.blre.2015.07.004_bb0230","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1111\/trf.12326","article-title":"An assessment of hepatitis E virus (HEV) in US blood donors and recipients: no detectable HEV RNA in 1939 donors tested and no evidence for HEV transmission to 362 prospectively followed recipients","volume":"53","author":"Xu","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2015.07.004_bb0235","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000357098","article-title":"Autochthonous Hepatitis E Virus Infections: A New Transfusion-Associated Risk?","volume":"41","author":"Dreier","year":"2014","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.blre.2015.07.004_bb0240","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1423-0410.2010.01362.x","article-title":"A nationwide survey for prevalence of hepatitis E virus antibody in qualified blood donors in Japan","volume":"99","author":"Takeda","year":"2010","journal-title":"Vox Sang"},{"key":"10.1016\/j.blre.2015.07.004_bb0245","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.3201\/eid1712.110371","article-title":"Hepatitis E virus antibodies in blood donors, France","volume":"17","author":"Mansuy","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.blre.2015.07.004_bb0250","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/S0140-6736(14)61034-5","article-title":"Hepatitis E virus in blood components: a prevalence and transmission study in southeast England","volume":"384","author":"Hewitt","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2015.07.004_bb0255","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4161\/pri.19430","article-title":"New generation QuIC assays for prion seeding activity","volume":"6","author":"Orru","year":"2012","journal-title":"Prion"},{"key":"10.1016\/j.blre.2015.07.004_bb0260","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/nprot.2012.067","article-title":"Protein misfolding cyclic amplification of infectious prions","volume":"7","author":"Morales","year":"2012","journal-title":"Nat Protoc"},{"key":"10.1016\/j.blre.2015.07.004_bb0265","doi-asserted-by":"crossref","first-page":"e69632","DOI":"10.1371\/journal.pone.0069632","article-title":"Plasminogen-based capture combined with amplification technology for the detection of PrP(TSE) in the pre-clinical phase of infection","volume":"8","author":"Segarra","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.blre.2015.07.004_bb0270","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/vox.12037","article-title":"Evaluation of a test for its suitability in the diagnosis of variant Creutzfeldt-Jakob disease","volume":"105","author":"Cooper","year":"2013","journal-title":"Vox Sang"},{"key":"10.1016\/j.blre.2015.07.004_bb0275","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jamaneurol.2013.6001","article-title":"Population Screening for Variant Creutzfeldt-Jakob Disease Using a Novel Blood Test: Diagnostic Accuracy and Feasibility Study","volume":"71","author":"Jackson","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.blre.2015.07.004_bb0280","doi-asserted-by":"crossref","first-page":"e1004202","DOI":"10.1371\/journal.ppat.1004202","article-title":"Preclinical detection of variant CJD and BSE prions in blood","volume":"10","author":"Lacroux","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.blre.2015.07.004_bb0285","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.3748\/wjg.v12.i32.5122","article-title":"Transfusion transmitted virus: A review on its molecular characteristics and role in medicine","volume":"12","author":"Irshad","year":"2006","journal-title":"World J Gastroenterol"},{"issue":"Suppl. 3","key":"10.1016\/j.blre.2015.07.004_bb0290","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1111\/trf.12213","article-title":"Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety?","volume":"53","author":"Stramer","year":"2013","journal-title":"Transfusion"},{"issue":"Suppl. 3","key":"10.1016\/j.blre.2015.07.004_bb0295","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1111\/trf.12316","article-title":"Human immunodeficiency virus transfusion transmission despite nucleic acid testing","volume":"53","author":"Salles","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2015.07.004_bb0300","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1111\/j.1537-2995.2009.02203.x","article-title":"First transmission of human immunodeficiency virus Type 1 by a cellular blood product after mandatory nucleic acid screening in Germany","volume":"49","author":"Schmidt","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2015.07.004_bb0305","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1537-2995.2011.03281.x","article-title":"Blood screening nucleic acid amplification tests for human immunodeficiency virus Type 1 may require two different amplification targets","volume":"52","author":"Chudy","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2015.07.004_bb0310","author":"Paul-Ehrlich-Institut"},{"key":"10.1016\/j.blre.2015.07.004_bb0315","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.2169\/internalmedicine.50.5458","article-title":"Erythroid crisis caused by parvovirus B19 transmitted via red blood cell transfusion","volume":"50","author":"Tsukada","year":"2011","journal-title":"Intern Med"},{"key":"10.1016\/j.blre.2015.07.004_bb0320","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1537-2995.2011.03289.x","article-title":"Relative distribution of West Nile virus RNA in blood compartments: implications for blood donor nucleic acid amplification technology screening","volume":"52","author":"Lai","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2015.07.004_bb0325","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/CMR.00063-09","article-title":"Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases","volume":"23","author":"Goncalves","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.blre.2015.07.004_bb0330","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/187152611794407746","article-title":"Approaches to minimize infection risk in blood banking and transfusion practice","volume":"11","author":"Lindholm","year":"2011","journal-title":"Infect Disord Drug Targets"},{"key":"10.1016\/j.blre.2015.07.004_bb0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12560-011-9056-7","article-title":"Minimum Infective Dose of the Major Human Respiratory and Enteric Viruses Transmitted Through Food and the Environment","volume":"3","author":"Yezli","year":"2011","journal-title":"Food Environ Virol"},{"key":"10.1016\/j.blre.2015.07.004_bb0340","doi-asserted-by":"crossref","first-page":"e1002512","DOI":"10.1371\/journal.ppat.1002512","article-title":"Mechanisms of pathogenesis, infective dose and virulence in human parasites","volume":"8","author":"Leggett","year":"2012","journal-title":"PLoS Pathol"},{"key":"10.1016\/j.blre.2015.07.004_bb0345","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1172\/JCI45449","article-title":"Cytomegalovirus: pathogen, paradigm, and puzzle","volume":"121","author":"Boeckh","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2015.07.004_bb0350","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1590\/S0037-86822010000400004","article-title":"Seroprevalence of cytomegalovirus antibodies in blood donors in southern, Brazil","volume":"43","author":"Souza","year":"2010","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.blre.2015.07.004_bb0355","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.0958-7578.2005.00556.x","article-title":"Hepatitis B virus vaccination of blood donors--what costs may be expected?","volume":"15","author":"Ringwald","year":"2005","journal-title":"Transfus Med"},{"key":"10.1016\/j.blre.2015.07.004_bb0360","doi-asserted-by":"crossref","first-page":"7797","DOI":"10.1016\/j.vaccine.2010.09.037","article-title":"A cost-benefit analysis of blood donor vaccination as an alternative to additional DNA testing for reducing transfusion transmission of hepatitis B virus","volume":"28","author":"Fischinger","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.blre.2015.07.004_bb0365","author":"World Health Organisation (WHO)"},{"key":"10.1016\/j.blre.2015.07.004_bb0370","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000314710","article-title":"Quarantine Plasma: Quo vadis?","volume":"37","author":"Roth","year":"2010","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.blre.2015.07.004_bb0375","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2796.2005.01451.x","article-title":"Pathogen inactivation technology: cleansing the blood supply","volume":"257","author":"Klein","year":"2005","journal-title":"J Intern Med"},{"key":"10.1016\/j.blre.2015.07.004_bb0380","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1160\/TH04-04-0229","article-title":"Contamination of coagulation factor concentrates with human parvovirus B19 genotype 1 and 2","volume":"92","author":"Schneider","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2015.07.004_bb0385","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/vox.12004","article-title":"Removal of TSE agent from plasma products manufactured in the United Kingdom","volume":"104","author":"Roberts","year":"2013","journal-title":"Vox Sang"},{"key":"10.1016\/j.blre.2015.07.004_bb0390","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.biologicals.2014.01.001","article-title":"Characterization of Thrombate III(R), a pasteurized and nanofiltered therapeutic human antithrombin concentrate","volume":"42","author":"Cai","year":"2014","journal-title":"Biologicals"},{"key":"10.1016\/j.blre.2015.07.004_bb0395","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1537-2995.2011.03425.x","article-title":"Comparison of nanofiltration efficacy in reducing infectivity of centrifuged versus ultracentrifuged 263K scrapie-infected brain homogenates in \"spiked\" albumin solutions","volume":"52","author":"Cardone","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2015.07.004_bb0400","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000324160","article-title":"Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light","volume":"38","author":"Marschner","year":"2011","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.blre.2015.07.004_bb0405","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000323845","article-title":"UVC Irradiation for Pathogen Reduction of Platelet Concentrates and Plasma","volume":"38","author":"Seltsam","year":"2011","journal-title":"Transfus Med Hemother"},{"issue":"Suppl. 1","key":"10.1016\/j.blre.2015.07.004_bb0410","doi-asserted-by":"crossref","first-page":"131S","DOI":"10.1111\/trf.12047","article-title":"Development of a riboflavin and ultraviolet light-based device to treat whole blood","volume":"53","author":"Reddy","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2015.07.004_bb0415","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1365-2516.2008.01695.x","volume":"14","author":"Keeling","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2015.07.004_bb0420","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1309\/AJCP6SBPOX0UWHEK","article-title":"Incidence of transfusion-related adverse reactions per patient reflects the potential risk of transfusion therapy in Japan","volume":"140","author":"Kato","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.blre.2015.07.004_bb0430","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/biot.200800241","article-title":"Emerging trends in plasma-free manufacturing of recombinant protein therapeutics expressed in mammalian cells","volume":"4","author":"Grillberger","year":"2009","journal-title":"Biotechnol J"},{"key":"10.1016\/j.blre.2015.07.004_bb0435","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1538-7836.2004.00731.x","article-title":"Is the incidence and prevalence of inhibitors greater with recombinant products? Yes","volume":"2","author":"Aledort","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2015.07.004_bb0440","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1182\/blood-2005-04-1371","article-title":"Influence of the type of factor VIII concentrate on the incidence of factor VIII inhibitors in previously untreated patients with severe hemophilia A","volume":"107","author":"Goudemand","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.blre.2015.07.004_bb0445","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1182\/blood-2012-09-457036","article-title":"Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study","volume":"121","author":"Gouw","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.blre.2015.07.004_bb0450","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0140-6736(06)68036-7","article-title":"Clinical perspectives of emerging pathogens in bleeding disorders","volume":"367","author":"Ludlam","year":"2006","journal-title":"Lancet"},{"issue":"Suppl. 2","key":"10.1016\/j.blre.2015.07.004_bb0455","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2006-946908","article-title":"Hemophilia therapy and blood-borne pathogen risk","volume":"32","author":"Knight","year":"2006","journal-title":"Semin Thromb Hemost"},{"issue":"Suppl. 5","key":"10.1016\/j.blre.2015.07.004_bb0460","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2516.2007.01572.x","article-title":"Creutzfeldt-Jakob disease: reflections on the risk from blood product therapy","volume":"13","author":"Brown","year":"2007","journal-title":"Haemophilia"},{"issue":"Suppl. 2","key":"10.1016\/j.blre.2015.07.004_bb0465","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/S0049-3848(10)70150-X","article-title":"EUHASS: The European Haemophilia Safety Surveillance system","volume":"127","author":"Makris","year":"2011","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2015.07.004_bb0470","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2516.2009.02181.x","article-title":"Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia","volume":"16","author":"Peden","year":"2010","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2015.07.004_bb0475","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0140-6736(10)62308-2","article-title":"Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay","volume":"377","author":"Edgeworth","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2015.07.004_bb0480","author":"World Health Organisation (WHO)"},{"key":"10.1016\/j.blre.2015.07.004_bb0485","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1373\/clinchem.2007.086595","article-title":"Development of a sensitive real-time reverse transcriptase PCR assay with an internal control to detect and quantify chikungunya virus","volume":"53","author":"Laurent","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.blre.2015.07.004_bb0490","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jcv.2007.04.015","article-title":"Development and evaluation of SYBR Green I-based one-step real-time RT-PCR assay for detection and quantification of Chikungunya virus","volume":"39","author":"Santhosh","year":"2007","journal-title":"J Clin Virol"},{"key":"10.1016\/j.blre.2015.07.004_bb0495","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1128\/CVI.05288-11","article-title":"Poor diagnostic accuracy of commercial antibody-based assays for the diagnosis of acute Chikungunya infection","volume":"18","author":"Blacksell","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.blre.2015.07.004_bb0505","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1128\/JCM.01403-07","article-title":"Detection of cytomegalovirus (CMV) DNA in EDTA whole-blood samples: evaluation of the quantitative artus CMV LightCycler PCR kit in conjunction with automated sample preparation","volume":"46","author":"Michelin","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.blre.2015.07.004_bb0510","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/1471-2334-13-387","article-title":"Detection of dengue viruses using reverse transcription-loop-mediated isothermal amplification","volume":"13","author":"Teoh","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.blre.2015.07.004_bb0520","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1128\/JCM.00842-06","article-title":"Development of multiplex real-time reverse transcriptase PCR assays for detecting eight medically important flaviviruses in mosquitoes","volume":"45","author":"Chao","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.blre.2015.07.004_bb0525","doi-asserted-by":"crossref","first-page":"e3171","DOI":"10.1371\/journal.pntd.0003171","article-title":"Evaluation of commercially available diagnostic tests for the detection of dengue virus NS1 antigen and anti-dengue virus IgM antibody","volume":"8","author":"Hunsperger","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.blre.2015.07.004_bb0530","author":"World Health Organisation (WHO)"},{"key":"10.1016\/j.blre.2015.07.004_bb0540","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4103\/0972-9747.45088","article-title":"Hepatitis B virus serology: Use and interpretation","volume":"4","author":"Shah","year":"2007","journal-title":"Hep B Annual"},{"key":"10.1016\/j.blre.2015.07.004_bb1000","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/PAT.0b013e3283631cf9","article-title":"The reliability of HBV core antibody in serological screening for hepatitis B virus","volume":"45","author":"Ba Alawi","year":"2013","journal-title":"Pathology"},{"key":"10.1016\/j.blre.2015.07.004_bb0550","author":"World Health Organisation (WHO)"},{"issue":"Suppl. 1","key":"10.1016\/j.blre.2015.07.004_bb0560","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1093\/cid\/cis368","article-title":"Laboratory diagnostics for hepatitis C virus infection","volume":"55","author":"Kamili","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2015.07.004_bb0565","doi-asserted-by":"crossref","first-page":"6701","DOI":"10.3748\/wjg.v20.i22.6701","article-title":"Hepatitis C virus core antigen testing: role in diagnosis, disease monitoring and treatment","volume":"20","author":"Tillmann","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.blre.2015.07.004_bb0570","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1055\/s-0034-1366618","article-title":"Hepatitis C diagnostics: clinical evaluation of the HCV-core antigen determination","volume":"52","author":"van Helden","year":"2014","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.blre.2015.07.004_bb0575","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4103\/0255-0857.90158","article-title":"Transfusion-transmitted hepatitis E: is screening warranted?","volume":"29","author":"Bajpai","year":"2011","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.blre.2015.07.004_bb0580","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1128\/JCM.03578-13","article-title":"Comparison of real-time PCR and antigen assays for detection of hepatitis E virus in blood donors","volume":"52","author":"Vollmer","year":"2014","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.blre.2015.07.004_bb0585","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1128\/JCM.05942-11","article-title":"Genotype 3 diversity and quantification of hepatitis E virus RNA","volume":"50","author":"Abravanel","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.blre.2015.07.004_bb0590","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1128\/JCM.01119-12","article-title":"Novel approach for detection of hepatitis E virus infection in German blood donors","volume":"50","author":"Vollmer","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.blre.2015.07.004_bb0595","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1086\/654801","article-title":"Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances","volume":"51","author":"Drobeniuc","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2015.07.004_bb0600","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00001432-200402000-00011","article-title":"Transmission and disease association of Kaposi's sarcoma-associated herpesvirus: recent developments","volume":"17","author":"Henke-Gendo","year":"2004","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.blre.2015.07.004_bb0610","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jim.2010.02.015","article-title":"Detection of antibodies to Kaposi's sarcoma-associated herpesvirus: a new approach using K8.1 ELISA and a newly developed recombinant LANA ELISA","volume":"356","author":"Mbisa","year":"2010","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.blre.2015.07.004_bb0615","author":"United Nations (UN)"},{"key":"10.1016\/j.blre.2015.07.004_bb0620","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00430-012-0249-y","article-title":"Comparison of HIV-1 viral load assay performance in immunological stable patients with low or undetectable viremia","volume":"202","author":"Naeth","year":"2013","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.blre.2015.07.004_bb0625","first-page":"24","article-title":"Laboratory diagnostics for HIV infection","volume":"46","author":"Butto","year":"2010","journal-title":"Ann Ist Super Sanita"},{"key":"10.1016\/j.blre.2015.07.004_bb0630","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3390\/v3071131","article-title":"Molecular determinants of human T-lymphotropic virus type 1 transmission and spread","volume":"3","author":"Lairmore","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.blre.2015.07.004_bb0645","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1742-4690-11-S1-P105","article-title":"Development and validation of a Multiplex Real-Time PCR for HTLV-1\/2 confirmatory diagnosis","volume":"11","author":"Rocha-Junior MH","year":"2014","journal-title":"Retrovirology"},{"key":"10.1016\/j.blre.2015.07.004_bb0650","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/jmv.21867","article-title":"Evaluation of a new screening assay for HTLV-1 and -2 antibodies for large-scale use","volume":"82","author":"Malm","year":"2010","journal-title":"J Med Virol"},{"key":"10.1016\/j.blre.2015.07.004_bb0655","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1590\/S0037-86822010000200001","article-title":"Evaluation of the use of real-time PCR for human T cell lymphotropic virus 1 and 2 as a confirmatory test in screening for blood donors","volume":"43","author":"Andrade","year":"2010","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.blre.2015.07.004_bb0660","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01970-13","article-title":"Keeping pace with Parvovirus B19 Genetic Variability: a Multiplex Genotype-Specific qPCR Assay","author":"Bonvicini","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.blre.2015.07.004_bb0665","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.0041-1132.2004.00610.x","article-title":"Quantitative real-time detection of parvovirus B19 DNA in plasma","volume":"44","author":"Koppelman","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2015.07.004_bb0670","first-page":"135","article-title":"Detection of human parvovirus B19, human bocavirus and human parvovirus 4 infections in blood samples among 95 patients with liver disease in Nanjing by nested PCR","volume":"27","author":"Tong","year":"2013","journal-title":"Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi"},{"key":"10.1016\/j.blre.2015.07.004_bb0675","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0166-0934(00)00227-5","article-title":"Detection of parvovirus B19 IgM by antibody capture enzyme immunoassay: receiver operating characteristic analysis","volume":"90","author":"Doyle","year":"2000","journal-title":"J Virol Methods"},{"key":"10.1016\/j.blre.2015.07.004_bb0680","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.3201\/eid1710.101841","article-title":"Placental transmission of human parvovirus 4 in newborns with hydrops, Taiwan","volume":"17","author":"Chen","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.blre.2015.07.004_bb0685","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3201\/eid1701.100750","article-title":"Serodiagnosis of primary infections with human parvovirus 4, Finland","volume":"17","author":"Lahtinen","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.blre.2015.07.004_bb0690","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3201\/eid1804.110628","article-title":"Human parvovirus 4 infection, Cameroon","volume":"18","author":"Lavoie","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.blre.2015.07.004_bb0695","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.3201\/eid1810.111836","article-title":"Human parvovirus 4 viremia in young children, Ghana","volume":"18","author":"May","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.blre.2015.07.004_bb0700","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3201\/eid1201.050916","article-title":"Novel parvovirus and related variant in human plasma","volume":"12","author":"Fryer","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.blre.2015.07.004_bb0705","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0140-6736(98)03056-6","article-title":"Detection of a novel DNA virus (TTV) in blood donors and blood products","volume":"352","author":"Simmonds","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2015.07.004_bb0710","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/1743-422X-10-191","article-title":"Validation of SYBR Green based quantification assay for the detection of human Torque Teno virus titers from plasma","volume":"10","author":"Tyagi","year":"2013","journal-title":"Virol J"},{"key":"10.1016\/j.blre.2015.07.004_bb0720","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.3390\/v5102329","article-title":"Diagnosis of west nile virus human infections: overview and proposal of diagnostic protocols considering the results of external quality assessment studies","volume":"5","author":"Sambri","year":"2013","journal-title":"Viruses"},{"key":"10.1016\/j.blre.2015.07.004_bb0725","doi-asserted-by":"crossref","first-page":"e2184","DOI":"10.1371\/journal.pntd.0002184","article-title":"Second international diagnostic accuracy study for the serological detection of West Nile virus infection","volume":"7","author":"Sanchini","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.blre.2015.07.004_bb0730","author":"World Health Organisation (WHO)"},{"key":"10.1016\/j.blre.2015.07.004_bb0735","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/sti.79.6.479","article-title":"Use of PCR in the diagnosis of early syphilis in the United Kingdom","volume":"79","author":"Palmer","year":"2003","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.blre.2015.07.004_bb0740","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1128\/JCM.00702-11","article-title":"Evaluation of a PCR test for detection of treponema pallidum in swabs and blood","volume":"50","author":"Grange","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.blre.2015.07.004_bb0745","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1155\/2005\/597580","article-title":"The laboratory diagnosis of syphilis","volume":"16","author":"Ratnam","year":"2005","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"10.1016\/j.blre.2015.07.004_bb0750","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.2174\/092986712799828355","article-title":"Current advances in detection and treatment of babesiosis","volume":"19","author":"Mosqueda","year":"2012","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.blre.2015.07.004_bb0755","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1128\/JCM.05848-11","article-title":"A new real-time PCR assay for improved detection of the parasite Babesia microti","volume":"50","author":"Teal","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.blre.2015.07.004_bb0760","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1128\/CVI.00313-12","article-title":"Multiplex assay detection of immunoglobulin G antibodies that recognize Babesia microti antigens","volume":"19","author":"Priest","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.blre.2015.07.004_bb0765","author":"World Health Organisation (WHO)"},{"key":"10.1016\/j.blre.2015.07.004_bb0770","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.2174\/092986712799828300","article-title":"Leishmaniasis: prevention, parasite detection and treatment","volume":"19","author":"Kobets","year":"2012","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.blre.2015.07.004_bb0775","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1471-2334-13-153","article-title":"Evaluation of PCR procedures for detecting and quantifying Leishmania donovani DNA in large numbers of dried human blood samples from a visceral leishmaniasis focus in Northern Ethiopia","volume":"13","author":"Abbasi","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.blre.2015.07.004_bb0780","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1128\/JCM.44.4.1435-1439.2006","article-title":"Comparison of PCR assays for diagnosis of cutaneous leishmaniasis","volume":"44","author":"Bensoussan","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.blre.2015.07.004_bb0785","author":"World Health Organisation (WHO)"},{"key":"10.1016\/j.blre.2015.07.004_bb0790","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4269\/ajtmh.2012.11-0685","article-title":"Emerging nucleic acid-based tests for point-of-care detection of malaria","volume":"87","author":"Cordray","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.blre.2015.07.004_bb0795","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1475-2875-2-39","article-title":"Serological detection of Plasmodium vivax malaria using recombinant proteins corresponding to the 19-kDa C-terminal region of the merozoite surface protein-1","volume":"2","author":"Rodrigues","year":"2003","journal-title":"Malar J"},{"key":"10.1016\/j.blre.2015.07.004_bb0800","author":"World Health Organisation (WHO)"},{"key":"10.1016\/j.blre.2015.07.004_bb0805","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CMR.18.1.133-146.2005","article-title":"Options for field diagnosis of human african trypanosomiasis","volume":"18","author":"Chappuis","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.blre.2015.07.004_bb0810","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1128\/JCM.01430-08","article-title":"Nucleic acid sequence-based amplification with oligochromatography for detection of Trypanosoma brucei in clinical samples","volume":"47","author":"Mugasa","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.blre.2015.07.004_bb0815","doi-asserted-by":"crossref","first-page":"e972","DOI":"10.1371\/journal.pntd.0000972","article-title":"Diagnostic accuracy of PCR in gambiense sleeping sickness diagnosis, staging and post-treatment follow-up: a 2-year longitudinal study","volume":"5","author":"Deborggraeve","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.blre.2015.07.004_bb0820","author":"World Health Organisation (WHO)"},{"key":"10.1016\/j.blre.2015.07.004_bb0825","doi-asserted-by":"crossref","first-page":"e931","DOI":"10.1371\/journal.pntd.0000931","article-title":"International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients","volume":"5","author":"Schijman","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.blre.2015.07.004_bb0830","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1128\/CVI.00127-07","article-title":"Evaluation of serological tests to identify Trypanosoma cruzi infection in humans and determine cross-reactivity with Trypanosoma rangeli and Leishmania spp","volume":"14","author":"Caballero","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.blre.2015.07.004_bb0835","doi-asserted-by":"crossref","first-page":"e1002924","DOI":"10.1371\/journal.ppat.1002924","article-title":"A novel rhabdovirus associated with acute hemorrhagic fever in central Africa","volume":"8","author":"Grard","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.blre.2015.07.004_bb0840","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1056\/NEJMc1106000","article-title":"A novel bunyavirus in China","volume":"365","author":"Bao","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2015.07.004_bb0845","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/cid\/cir804","article-title":"Hemorrhagic fever caused by a novel Bunyavirus in China: pathogenesis and correlates of fatal outcome","volume":"54","author":"Zhang","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2015.07.004_bb0850","doi-asserted-by":"crossref","first-page":"20632","DOI":"10.3402\/ehtj.v6i0.20632","article-title":"What we are watching--five top global infectious disease threats, 2012: a perspective from CDC's Global Disease Detection Operations Center","volume":"6","author":"Christian","year":"2013","journal-title":"Emerg Health Threats J"},{"key":"10.1016\/j.blre.2015.07.004_bb0855","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/1743-422X-10-203","article-title":"Surveillance on A\/H5N1 virus in domestic poultry and wild birds in Egypt","volume":"10","author":"El-Zoghby","year":"2013","journal-title":"Virol J"},{"key":"10.1016\/j.blre.2015.07.004_bb0860","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0140-6736(13)61171-X","article-title":"Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a population-based study of laboratory-confirmed cases","volume":"382","author":"Cowling","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2015.07.004_bb0865","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/MCP.0000000000000047","article-title":"Viral lung infections: Epidemiology, virology, clinical features, and management of avian influenza A(H7N9)","volume":"20","author":"To","year":"2014","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.blre.2015.07.004_bb0870","doi-asserted-by":"crossref","first-page":"e1000455","DOI":"10.1371\/journal.ppat.1000455","article-title":"Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from southern Africa","volume":"5","author":"Briese","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.blre.2015.07.004_bb0875","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.3201\/eid1510.090211","article-title":"Nosocomial outbreak of novel arenavirus infection, southern Africa","volume":"15","author":"Paweska","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.blre.2015.07.004_bb0880","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/infdis\/jit292","article-title":"Marseillevirus-like virus recovered from blood donated by asymptomatic humans","volume":"208","author":"Popgeorgiev","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.blre.2015.07.004_bb0885","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jcv.2013.10.001","article-title":"Marseillevirus prevalence in multitransfused patients suggests blood transmission","volume":"58","author":"Popgeorgiev","year":"2013","journal-title":"J Clin Virol"},{"key":"10.1016\/j.blre.2015.07.004_bb0890","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(13)61887-5","article-title":"Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study","author":"Cotten","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2015.07.004_bb0895","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0140-6736(13)61492-0","article-title":"Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk","volume":"382","author":"Breban","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2015.07.004_bb0900","author":"Centers for Disease Control and Prevention (CDC)"},{"key":"10.1016\/j.blre.2015.07.004_bb0905","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.3748\/wjg.v9.i8.1635","article-title":"Current status of severe acute respiratory syndrome in China","volume":"9","author":"Nie","year":"2003","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.blre.2015.07.004_bb0910","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1098\/rstb.2004.1482","article-title":"Confronting SARS: a view from Hong Kong","volume":"359","author":"Peiris","year":"2004","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.blre.2015.07.004_bb0915","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/infdis\/jiu250","article-title":"Identification of a novel polyomavirus in a pancreatic transplant recipient with retinal blindness and vasculitic myopathy","volume":"210","author":"Mishra","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.blre.2015.07.004_bb0920","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1093\/infdis\/jiu443","article-title":"No evidence of Marseillevirus-like virus presence in blood donors and recipients of multiple blood transfusions","volume":"210","author":"Sauvage","year":"2014","journal-title":"J Infect Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.blre.2015.07.004_bb0925","doi-asserted-by":"crossref","first-page":"S270","DOI":"10.1086\/655651","article-title":"The detection of acute HIV infection","volume":"202","author":"Cohen","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.blre.2015.07.004_bb0930","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1128\/JCM.00121-10","article-title":"Improving HIV-2 detection by a combination of serological and nucleic acid amplification test assays","volume":"48","author":"Ciccaglione","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.blre.2015.07.004_bb0940","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.respe.2012.09.005","article-title":"Prevalence and incidence of HIV and hepatitis B among blood donors and estimated residual risk of transmission of HIV and HBV virus by blood transfusion. A study at the Provincial General Referee Hospital Bukavu, Democratic Republic of the Congo","volume":"61","author":"Namululi","year":"2013","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.blre.2015.07.004_bb0945","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/vox.12028","article-title":"Risk factors for human immunodeficiency virus infection among Brazilian blood donors: a multicentre case-control study using audio computer-assisted structured interviews","volume":"105","author":"de Almeida-Neto","year":"2013","journal-title":"Vox Sang"},{"key":"10.1016\/j.blre.2015.07.004_bb0950","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/trf.12003","article-title":"The diversity of chronic hepatitis B virus infections within blood donors in England and North Wales 2005 through 2010","volume":"53","author":"Rosenberg","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2015.07.004_bb0955","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/vox.12060","article-title":"A method for estimating the residual risk of transfusion-transmitted HBV infection associated with occult hepatitis B virus infection in a donor population without universal anti-HBc screening","volume":"105","author":"Seed","year":"2013","journal-title":"Vox Sang"},{"key":"10.1016\/j.blre.2015.07.004_bb0960","first-page":"907","article-title":"[HIV, HCV, HBV and syphilis surveillance among blood donors in Germany 2008-2010]. Bundesgesundheitsblatt, Gesundheitsforschung","volume":"55","author":"Offergeld","year":"2012","journal-title":"Gesundheitsschutz"},{"key":"10.1016\/j.blre.2015.07.004_bb0965","doi-asserted-by":"crossref","first-page":"371","DOI":"10.20344\/amp.190","article-title":"Evolution of residual risk for HIV, HCV and HBV, from 1999 to 2010, in blood donations of the Centro Hospitalar S. Joao, EPE, Porto, Portugal","volume":"26","author":"Koch","year":"2013","journal-title":"Acta Med Port"},{"key":"10.1016\/j.blre.2015.07.004_bb0970","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/vox.12056","article-title":"Hepatitis E virus in Scottish blood donors","volume":"105","author":"Cleland","year":"2013","journal-title":"Vox Sang"},{"key":"10.1016\/j.blre.2015.07.004_bb0975","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1423-0410.2011.01583.x","article-title":"Occurrence of hepatitis E virus RNA in plasma donations from Sweden, Germany and the United States","volume":"103","author":"Baylis","year":"2012","journal-title":"Vox Sang"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X15000594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X15000594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T06:20:47Z","timestamp":1691821247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X15000594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":185,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0268960X15000594"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2015.07.004","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current concepts in the prevention of pathogen transmission via blood\/plasma-derived products for bleeding disorders","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2015.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}